What is the latest price of Guanfacine in 2025?

Guanfacine extended-release tablets (trade name: Intuniv) are used to control attention deficit hyperactivity disorder (ADHD), a disorder in which patients have difficulty concentrating, controlling behavior, and staying quiet. As a centrally acting α2a adrenergic receptor agonist, guanfacine treats symptoms associated with ADHD by affecting areas of the brain that control attention and impulsivity.

Guanfacine is available in tablets and oral sustained-release tablets. Sustained-release tablets usually need to be taken once a day and should not be taken with high-fat meals. For best results, advise patients to take guanfacine at the same time each day and to swallow the extended-release tablets whole with a small amount of water or other liquid and not to break, chew, or crush them. This method of use facilitates the gradual release of the drug, thereby maintaining stable drug concentration and effect.

At the beginning of medication, doctors may advise patients to start with a low dose and then gradually increase the dose. Especially when using sustained-release tablets, each dose adjustment should be kept once a week. Although guanfacine is effective in controlling ADHD symptoms, it is important to note that it does not cure the disease. It usually takes about two weeks for patients to feel the full benefits of the extended-release tablets, so you should continue taking guanfacine even after you feel well after taking the drug to ensure a stable and long-lasting effect.

The original drug of guanfacine has not yet been launched in China, so its price and medical insurance and other related information are still unclear. At present, this drug has been launched in many overseas countries. Taking the original research version in Japan as an example, each box of 1mg*100 tablets may be sold for more than 3,000 yuan. The specific price will change due to exchange rate fluctuations. In addition, there are currently no generic versions of guanfacine available in overseas markets, which requires patients to pay attention to the source and availability of the drug when choosing treatment.

Reference materials:https://medlineplus.gov/druginfo/meds/a601059.html